MedPath

CLEVELAND CLINIC ABUDHABI L L C

🇦🇪United Arab Emirates
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

P0.1 and Extubation Failure in Critically Ill Patients

Not yet recruiting
Conditions
Critically Ill
Mechanical Ventilation
Weaning Failure
First Posted Date
2023-04-07
Last Posted Date
2023-04-07
Lead Sponsor
Cleveland Clinic Abu Dhabi
Target Recruit Count
120
Registration Number
NCT05802745
Locations
🇫🇷

Amiens University Hospital, Amiens, France

🇫🇷

Centre Hospitalier d'Arras, Arras, France

🇫🇷

Dijon University Hospital, Dijon, France

Correlation Between New O3 Regional Oximetry, Electroencephalography and the Somatosensory Evoked Potential in Carotid Endarterectomy Surgery

Recruiting
Conditions
Carotid Endarterectomy
First Posted Date
2022-03-04
Last Posted Date
2024-02-07
Lead Sponsor
Cleveland Clinic Abu Dhabi
Target Recruit Count
10
Registration Number
NCT05267782
Locations
🇦🇪

Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates

The Alternative Position for the SedLine® Sensor

Completed
Conditions
Depth of Anesthesia Monitoring
First Posted Date
2019-05-13
Last Posted Date
2020-07-15
Lead Sponsor
Cleveland Clinic Abu Dhabi
Target Recruit Count
40
Registration Number
NCT03947060
Locations
🇦🇪

Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates

Pharmacokinetics of Antibiotics in Patients Undergoing Renal Replacement Therapies

Recruiting
Conditions
Renal Replacement Therapy
First Posted Date
2018-08-17
Last Posted Date
2023-02-08
Lead Sponsor
Cleveland Clinic Abu Dhabi
Target Recruit Count
200
Registration Number
NCT03636464
Locations
🇦🇪

Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates

News

NeOnc Technologies Secures $50 Million Investment to Expand Brain Cancer Clinical Trials in MENA Region

NeOnc Technologies signed a non-binding term sheet with Quazar Investment for a $50 million equity investment to establish a UAE-based clinical platform focused on the Middle East and North Africa region.

M42, AstraZeneca, and SOPHiA GENETICS Launch UAE Liquid Biopsy Initiative to Transform Cancer Diagnosis

M42, AstraZeneca, and SOPHiA GENETICS announced a strategic collaboration to bring cutting-edge liquid biopsy testing to the UAE, enabling non-invasive genomic profiling through simple blood draws.

Cleveland Clinic Abu Dhabi Pioneers First GCC Breast Cancer Recurrence Trial with AstraZeneca

The Fatima bint Mubarak Center at Cleveland Clinic Abu Dhabi becomes the first GCC facility to join a global Phase 3 trial testing a novel SERD anti-estrogen medication for breast cancer recurrence prevention.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.